Pharvaris N.V. ( PHVS) - Stock Earnings
PHVS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026, midnight | — / — | — | — / — | — |
PHVS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -54.9 million USD | — USD |
| 2026Q1 | -45.7 million USD | — USD |
| 2026Q2 | -54.6 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
PHVS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -111.5 million USD | — USD |
| 2024 | -139.8 million USD | — USD |
| 2025 | -206.3 million USD | — USD |
| 2026 Est. | — | — |
PHVS
Price: $30.68
52 week price:
Earnings Per Share: -3.00 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Netherlands
Volume: 38200
Market Capitalization: 2.2 billion